Regulatory ProfessionalsRegulatory ProfessionalsRegulatory ProfessionalsRegulatory Professionals
  • About Us
    • Our Story
    • Leadership
    • Senior Consultants
  • Services
    • Overview
    • Regulatory Affairs Strategy
    • Electronic Publishing | eCTD
    • Medical and Regulatory Writing
    • Quality Assurance
    • Project Management
    • Electronic Trial Master File | eTMF
  • Resources
    • Blog
    • White Papers
    • News
  • Careers
  • Contact

Senior Consultants

Brian Masters, Ph.D

Director, Medical & Regulatory Writing
Brian Masters has significant experience in medical and regulatory writing, including authoring and reviewing documents for medical communications and regulatory submissions for investigational new drugs, new drug applications, biologics license applications, and marketing authorization applications. Prior to joining RPI, Dr. Masters was a principal medical writer for several large pharma/biopharma sponsors, including Onyx, Astellas, Merrimack, Merck, and Otsuka Pharmaceuticals, where he specialized in a broad range of therapeutic areas, including oncology, immunology/rheumatology, neurological disorders, infectious diseases, cardiovascular diseases, diabetes and metabolism, blood disorders, respiratory disorders, transplantation and cell therapy, and rare diseases. Before entering the pharma/biopharma industry, he spent 10 years as a professor and independent research scientist at the University of Miami School of Medicine, where he conducted research on stem cells and neurodevelopment. He has a Ph.D. in cellular and integrative neurosciences from the University of Florida in Gainesville and has completed fellowships in molecular genetics and genomics at the Howard Hughes Medical Institute.

Irene Figari

Senior Director, Regulatory Affairs
Irene Figari brings 40 years of biotech experience to the RPI regulatory affairs team. She spent the first 16 years of her career in basic research and development, focusing on immunology, cell biology, tumor model systems, and molecular biology. She then moved to the regulatory side in roles of increasing responsibility and leadership. She led a team of regulatory professionals in providing strategic and tactical guidance across therapeutic areas and disciplines in the clinical; nonclinical; and chemistry, manufacturing, and controls arenas. That team delivered both regional and international regulatory strategy for pharmaceutical and biotech drug development teams. She has also provided regulatory leadership and development of strategy for products from the pre-investigational new drug (IND) stage through post-marketing in multiple therapeutic areas, with a focus on oncology. A decisive and results-oriented leader recognized for both project and people management, Irene easily adapts to sudden requests and unforeseen detours. Her accomplishments include leading teams to successful global health authority interactions, INDs, orphan drug applications, fast track applications, pediatric strategies, and marketing applications.

Aurora Sosa, M.A.

Director, Regulatory Affairs
Aurora Sosa brings significant experience in regulatory strategy, regulatory management, and planning to the RPI regulatory affairs team. Prior to entering the industry, she worked in academic research for about 10 years. Ms. Sosa’s experience includes contributing to international teams developing small and large molecules as well as biologics in a broad range of therapeutic areas, including immunologic, neurological, gastrointestinal, respiratory, and blood disorders, as well as dermatology, infectious diseases, and cardiovascular disease. Prior to joining RPI, she was a regulatory leader and contributor at Bayer Biologics, Corus/Gilead Sciences, ARCA Biopharma, Dow Pharmaceuticals/Valeant Pharmaceuticals, Cerexa/Forest Laboratories, and Ardelyx. Ms. Sosa holds a B.S. in biology from Trinity University and has an M.A. in counseling psychology from John F. Kennedy University’s School of Consciousness.

Naomi Kautz, M.S.

Director, Regulatory Affairs
Naomi Kautz brings 20 years of multidisciplinary experience in the biotechnology and pharmaceutical industries to the RPI regulatory affairs team. She has focused on regulatory affairs, research and development, and policy since completing her academic training in biochemistry. Her 15-year tenure in regulatory affairs has spanned development from early through late stage, including new drug application filings. She has also served as U.S. regulatory lead and global regulatory lead on late-stage programs. Since 2009, she has focused on regulatory affairs related to the development of cell and gene therapy. Ms. Kautz has worked on several programs with immuno-oncology agents, including chimeric antigen receptor T-cell therapies, as well as cell and gene therapies for neurodegenerative conditions. She has a B.S. from the University of Guelph and an M.S. from Queen’s University.

Maurice Bancsi, Ph.D.

Director, EU Regulatory Affairs
Maurice Bancsi focuses on regulatory strategy for Europe and the European Union in conjunction with clients across all stages of development. He brings significant experience in regulatory affairs in the pharmaceutical and biotech industry to his role. Prior to joining RPI, Dr. Bancsi served as an EU regulatory liaison in oncology at Janssen Biologics for 16 years, providing regulatory leadership for products across development stages, from pre first-in-human through marketing authorization. He was also involved in regulatory procedures, including pediatric investigation plan waivers; orphan applications; marketing authorization applications; Committee for Medicinal Products for Human Use scientific advice; national scientific advice for the UK, Sweden, Netherlands, Germany, France, and Spain; and Type I and II variations. Recently, Dr. Bancsi has focused on real-world evidence implications for global regulatory strategies and the use of digital technologies in clinical trials. He holds an M.S. in medical biology from the University of Utrecht and a Ph.D. in bacterial endocarditis from the University of Leiden, both in the Netherlands.

Headquarters

8000 Jarvis Ave.
Suite 100
Newark, CA 94560

North Carolina

One Park Drive, Suite 150
Box 13608
Research Triangle Park,
NC 27709

San Diego

Aventine Building
8910 University Center Lane
Suite 400 San Diego, CA 92122

United Kingdom

250 South Oak Way
Green Park
Reading, Berkshire, RG2 6UG

Australia

Premier Research Australia Pty Ltd.
Ground Floor, 23 Milton Parade
Malvern VIC 3144

  • Home
  • About Us
  • Services
  • Cookie Policy
  • Privacy Notice
  • Contact
Copyright 2020 Regulatory Professionals | All Rights Reserved
  • About Us
    • Our Story
    • Leadership
    • Senior Consultants
  • Services
    • Overview
    • Regulatory Affairs Strategy
    • Electronic Publishing | eCTD
    • Medical and Regulatory Writing
    • Quality Assurance
    • Project Management
    • Electronic Trial Master File | eTMF
  • Resources
    • Blog
    • White Papers
    • News
  • Careers
  • Contact
Regulatory Professionals
XWe use cookies (and equivalent technologies) to collect and analyze information on our Website’s performance and to enable the Website to function. Cookies also allow us and third parties to tailor the ads you see when you visit our Website and other third party websites in the same online network, including social networks. By clicking ‘AGREE', you agree to these uses of cookies. If you do not agree or if you would like more information, you can manage your cookie preferences by clicking on 'Cookie Settings'. Cookie Policy REJECTAGREECookie Settings
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non Necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Save & Accept